Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-09

FDA Approved: AZACITIDINE — Supplemental Application (Dr. Reddy's Laboratories Inc.)

View source ↗

Summary

The FDA approved a supplemental application for azacitidine from Dr. Reddy's Laboratories Inc. (ANDA201537).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZACITIDINE (AZACITIDINE)

Snippet

SUPPL AP for AZACITIDINE (AZACITIDINE)